Healthcare
Bittium Wearable Platform with Philips EmoGraphy & CardioSense Solution Was Awarded in the GSK’s “Transform the Future of Self-Care” Innovation Contest
CENTOGENE revealed the growth in its knowledge-base of rare hereditary diseases.
An article published in Experimental Biology and Medicine identifies a new target for the treatment of idiopathic pulmonary fibrosis.
National Cancer Control Efforts Should Address the System, Not Its Individual Parts, Says New Report
Current cancer control efforts in the United States typically are fragmented and uncoordinated, but taking a systems approach to establish a U.S. National Cancer Control Plan would address the challenge more holistically, says a new report from the National Academies of Sciences, Engineering, and Medicine.
Driving personalized, immune-based therapy to target patients’ own immune responses
Vivoryon Therapeutics AG, announced that they have entered into a research collaboration with University Medical Center Schleswig-Holstein, Campus Kiel, to discover and develop first-in-class therapeutics in cancer immunotherapy.
DS Pharma Animal Health awards Hacarus the Grand Prize for ‘New Business Solutions in Animal Health’
Hacarus Inc, the leading provider of lightweight and explainable AI, was awarded the Grand Prize by DS Pharma Animal Health for its innovative AI-enabled technology platform ‘HACARUS.ai’
CENTOGENE biomarker measures lyso-Gb1 levels in children
Admedus Ltd announces the publication of an independent study assessing the performance of CardioCel® in the prestigious peer-reviewed journal, The Annals of Thoracic Surgery.
The company will focus on chemoproteomics, which it calls a way of interrogating proteins in living systems. This allows them to identify potential new binding targets on proteins, which will allow the development of small-molecule drugs.
PRESS RELEASES